GEODE CAPITAL MANAGEMENT, LLC - TOKAI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TOKAI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$70,000
-16.7%
84,831
-1.7%
0.00%
Q4 2016$84,000
-25.7%
86,328
+16.4%
0.00%
Q3 2016$113,000
-64.6%
74,171
+27.9%
0.00%
Q2 2016$319,000
+8.5%
57,977
+10.3%
0.00%
Q1 2016$294,000
-35.8%
52,554
-0.1%
0.00%
Q4 2015$458,000
-13.4%
52,619
+2.8%
0.00%
Q3 2015$529,000
-7.4%
51,191
+19.1%
0.00%
Q2 2015$571,000
+26.3%
42,995
+7.3%
0.00%
Q1 2015$452,000
-18.4%
40,088
+6.7%
0.00%
Q4 2014$554,00037,5850.00%
Other shareholders
TOKAI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 637,110$3,574,187,0000.71%
Novo Holdings A/S 470,946$2,642,0000.29%
Perceptive Advisors 485,338$2,723,0000.24%
SABBY MANAGEMENT, LLC 812,200$4,556,0000.23%
FNY Managed Accounts LLC 6,438$36,117,0000.06%
NJ State Employees Deferred Compensation Plan 35,000$271,0000.06%
Alyeska Investment Group, L.P. 315,757$1,771,0000.02%
ROPES WEALTH ADVISORS LLC 6,000$34,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 60,000$337,0000.01%
BlackRock Fund Advisors 530,538$2,976,0000.00%
View complete list of TOKAI PHARMACEUTICALS INC shareholders